effectors < effects < efficacious

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 114.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000022 (2011)	Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]	Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000041 (2014)	P. Jayasekera [Royaume-Uni] ; R. Parslew [Royaume-Uni] ; A. Al-Sharqi [Royaume-Uni]	A case of tumour necrosis factor‐α inhibitor‐ and rituximab‐induced plantar pustular psoriasis that completely resolved with tocilizumab
000049 (2012)	Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]	Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000066 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000069 (2016)	Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]	Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000071 (2010)	A. Gause [Allemagne] ; A. Rubbert-Roth [Allemagne] ; H. Michels [Allemagne] ; M. Gaubitz [Allemagne] ; W.-J. Mayet [Allemagne]	Empfehlungen der Deutschen Gesellschaft für Rheumatologie zum Einsatz von Tocilizumab bei der rheumatoiden Arthritis (Februar 2010)
000085 (2011)	Hiroki Wakabayashi [Japon] ; Akihiro Sudo [Japon] ; Yosuke Nishioka [Japon] ; Masahiro Hasegawa [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon]	Repeat etanercept administration restores clinical response of patients with rheumatoid arthritis
000088 (2011)	Emily Beth Devine [États-Unis] ; Rafael Alfonso-Cristancho [États-Unis] ; Sean D. Sullivan [États-Unis]	Effectiveness of Biologic Therapies for Rheumatoid Arthritis: An Indirect Comparisons Approach
000100 (2012)	K. Tenbrock [Allemagne]	Therapie der juvenilen idiopathischen Arthritis (JIA)
000101 (2012)	K. Krüger [Allemagne]	Medikamentöse Interaktionen in der Rheumatologie
000117 (2010)	C. B. Confavreux [France] ; R. D. Chapurlat [France]	Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
000120 (2011)	Rene Thonhofer [Autriche] ; Manuela Hiller [Autriche] ; Horst Just [Autriche] ; Markus Trummer [Autriche] ; Cornelia Siegel [Autriche] ; Christian Dejaco [Autriche]	Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature
000125 (2012)	Nicolas Rohleder [États-Unis] ; Martin Aringer [Allemagne] ; Matthias Boentert [Allemagne]	Role of interleukin‐6 in stress, sleep, and fatigue
000133 (2009)	Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]	Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
000137 (2011)		Adverse effects of biologics: a network meta‐analysis and Cochrane overview
000155 (2009)	Misato Hashizume [Japon] ; Naohiko Hayakawa [Japon] ; Miho Suzuki [Japon] ; Masahiko Mihara [Japon]	IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system
000176 (2010)	I. H. Tarner [Allemagne] ; U. Müller-Ladner [Allemagne] ; C. Hamm [Allemagne]	Biologika und kardiovaskuläres Risiko
000179 (2009)	Masahiko Mihara [Japon] ; Yoshiyuki Ohsugi [Japon] ; Tadamitsu Kishimoto	Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody
000195 (2010)	Luciana Breda [Italie] ; Marianna Del Torto [Italie] ; Sara De Sanctis [Italie] ; Francesco Chiarelli [Italie]	Biologics in children’s autoimmune disorders: efficacy and safety
000204 (2010)	C. J. Edwards [Royaume-Uni] ; E. Williams [Royaume-Uni]	The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
000205 (2012)	A. Rubbert-Roth [Allemagne] ; H.-F. Petereit [Allemagne]	Nebenwirkungen der medikamentösen Therapie rheumatischer Erkrankungen am Nervensystem

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "effects" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "effects" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    effects
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021